Physician profile
Brandon E Bulmer
NPI 1659143907
$1,026.19
in general payments reported to CMS, 2019-2025
10 companies · $618 in 2025
The $618 reported for 2025 was more than what 80% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $408 · 2025: $618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,026.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $267.38 | 2024-2025 | Carto 3 |
| Kestra Medical Technology Services, INC. | $247.05 | 2025 | Assure Wcd |
| Abiomed | $165.81 | 2024-2025 | Impella |
| Boston Scientific Corporation | $151.51 | 2024-2025 | Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd, General - Crm_crm |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.17 | 2024-2025 | Lifevest |
| Cardiva Medical, INC. | $42.93 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Haemonetics Corporation | $36.24 | 2025 | Teg6s Hemostasis System |
| Cordis US Corp. | $30.91 | 2025 | Mynx Control Venous |
| Becton, Dickinson and Company | $14.76 | 2025 | |
| Medtronic, INC. | $14.43 | 2024 | Micra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Bulmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.